ARTICLE | Company News
Former Insys CEO pleads guilty to opioid prescription kickbacks
January 11, 2019 6:30 PM UTC
Michael Babich, former president and CEO of Insys Therapeutics Inc. (NASDAQ:INSY), pleaded guilty on Jan. 9 in conspiring to bribe physicians to unnecessarily prescribe Subsys fentanyl sublingual spray and defraud insurance companies.
The opioid is approved in the U.S. to treat breakthrough cancer pain...
BCIQ Company Profiles